Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence? Ewig S. Eur Respir J 2002; 19: 387-389 | |
Minimal clinically significant difference in health status: the thorny path of health status measures? Hajiro T., Nishimura K. Eur Respir J 2002; 19: 390-391 | |
Serological evidence of Legionella species infection in acute exacerbation of COPD Lieberman D., Lieberman D., Shmarkov O., Gelfer Y., Ben-Yaakov M., Lazarovich Z., Boldur I. Eur Respir J 2002; 19: 392-397 | |
Interpreting thresholds for a clinically significant change in health status in asthma and COPD Jones P.W. Eur Respir J 2002; 19: 398-404 | |
Interpretation of quality of life scores from the St George's Respiratory Questionnaire Ferrer M., Villasante C., Alonso J., Sobradillo V., Gabriel R., Vilagut G., Masa J.F., Viejo J.L., Jimenez-Ruiz C.A., Miravitlles M. Eur Respir J 2002; 19: 405-413 | |
A national study of medical care expenditures for respiratory conditions Yelin E., Trupin L., Cisternas M., Eisner M., Katz P., Blanc P. Eur Respir J 2002; 19: 414-421 | |
Effects of lung volume reduction surgery in hamsters with elastase-induced emphysema Marchand E., De Leyn P., Gayan-Ramirez G., Palecek F., Verbeken E., Decramer M. Eur Respir J 2002; 19: 422-428 | |
Effect of chest wall vibration on the canine diaphragm during breathing Leduc D., De Troyer A. Eur Respir J 2002; 19: 429-433 | |
Relationship between supramaximal flow during cough and mortality in motor neurone disease Chaudri M.B., Liu C., Hubbard R., Jefferson D., Kinnear W.J. Eur Respir J 2002; 19: 434-438 | |
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Greene K.E., King T.E., Kuroki Y., Bucher-Bartelson B., Hunninghake G.W., Newman L.S., Nagae H., Mason R.J. Eur Respir J 2002; 19: 439-446 | |
Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice Miyakawa H., Sato K., Shinbori T., Okamoto T., Gushima Y., Fujiki M., Suga M. Eur Respir J 2002; 19: 447-457 | |
Survey of flexible fibreoptic bronchoscopy in the United Kingdom Smyth C.M., Stead R.J. Eur Respir J 2002; 19: 458-463 | |
Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Egermann U., Jaeggi K., Habicht J.M., Perruchoud A.P., Dalquen P., Soler M. Eur Respir J 2002; 19: 464-468 | |
Achilles tendon disease in lung transplant recipients: association with ciprofloxacin Chhajed P.N., Plit M.L., Hopkins P.M., Malouf M.A., Glanville A.R. Eur Respir J 2002; 19: 469-471 | |
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients Ward C., Walters E.H., Zheng L., Whitford H., Williams T.J., Snell G.I. Eur Respir J 2002; 19: 472-478 | |
Associations between markers of respiratory morbidity in European children Timonen K.L., Schwartz J., Nielsen J., Brunekreef B. Eur Respir J 2002; 19: 479-486 | |
Elevated nitrite in breath condensates of children with respiratory disease Formanek W., Inci D., Lauener R.P., Wildhaber J.H., Frey U., Hall G.L. Eur Respir J 2002; 19: 487-491 | |
Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis Goetghebeur D., Sarni D., Grossi Y., Leroyer C., Ghezzo H., Milic-Emili J., Bellet M. Eur Respir J 2002; 19: 492-498 | |
Health-related quality of life in obstructive sleep apnoea Lacasse Y., Godbout C., Series F. Eur Respir J 2002; 19: 499-503 | |
Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease Dancey D.R., Tullis E.D., Heslegrave R., Thornley K., Hanly P.J. Eur Respir J 2002; 19: 504-510 | |
Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study Elmasry A., Lindberg E., Hedner J., Janson C., Boman G. Eur Respir J 2002; 19: 511-517 | |
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation Beghetti M., Reber G., de Moerloose P., Vadas L., Chiappe A., Spahr-Schopfer I., Rimensberger P.C. Eur Respir J 2002; 19: 518-524 | |
Role of tyrosine phosphatase in the modulation of pulmonary vascular tone Huang X.L., El Kebir D., De Buys Roessingh A.S., Schneider J.C., Jacob L., Mercier J.C., Dall'Ava-Santucci J., Dinh-Xuan A.T. Eur Respir J 2002; 19: 525-529 | |
Recording flow in the first second of a maximal forced expiratory manoeuvre: influence of frequency content Miller M.R., Lloyd J., Bright P. Eur Respir J 2002; 19: 530-533 | |
Free, soluble interleukin-17 protein during severe inflammation in human airways Laan M., Palmberg L., Larsson K., Linden A. Eur Respir J 2002; 19: 534-537 | |
Interactions between respiratory tract infections and atopy in the aetiology of asthma Holt P.G., Sly P.D. Eur Respir J 2002; 19: 538-545 | |
Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae von Hertzen L.C. Eur Respir J 2002; 19: 546-556 | |
Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Brock C.S., Lee S.M. Eur Respir J 2002; 19: 557-570 | |
Pulmonary hypertension in collagen vascular disease Hoeper M.M. Eur Respir J 2002; 19: 571-576 | |
Statin-induced fibrotic nonspecific interstitial pneumonia Lantuejoul S., Brambilla E., Brambilla C., Devouassoux G. Eur Respir J 2002; 19: 577-580 | |
An 11-yr-old male with pneumonia and persistent airway obstruction Niggemann B., Gerstner B., Guschmann M., Paul K., Wit J., Mau H., Wahn U. Eur Respir J 2002; 19: 582-584 | |
Physical exercise, sports, and lung function in smoking versus nonsmoking adolescents. T.L. Holmen, E. Barrett-Connor, J. Clausen, J. Holmen, L. Bjermer. Eur Respir J 2002; 19: 585 | |